BMC Infectious Diseases

official impact factor 2.83

Open Access Email this article to a friend

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

David Ben-Nathan*, Orly Gershoni-Yahalom, Itzchak Samina, Yevgeny Khinich, Israel Nur, Orgad Laub, Ahuva Gottreich, Michael Simanov, Angel Porgador, Bracha Rager-Zisman and Nadav Orr

BMC Infectious Diseases 2009, 9:18 doi:10.1186/1471-2334-9-18

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.